Blepharospasm is a neurological movement disorder characterized by involuntary, bilateral, repetitive contractions of the orbicularis oculi — the ring-shaped muscle surrounding each eye — resulting in abnormal blinking, forced squinting, or in severe cases, sustained eyelid closure producing functional blindness. It is classified in ICD-10-CM under G24 (Dystonia), a subcategory of Extrapyramidal and movement disorders (G20-G26), placing it firmly in the Diseases of the Nervous System chapter — not the eye chapter (H00-H59) — a classification distinction that carries direct coding consequences. The most common clinical presentation is Benign Essential Blepharospasm (BEB), a bilateral focal dystonia with no identifiable structural cause, distinguished from secondary blepharospasm (caused by ocular surface irritation, blepharitis, keratoconjunctivitis) and drug-induced blepharospasm (coded separately to G24.01). BEB is progressive: it typically begins with increased blink rate and photophobia, then advances to involuntary forced closure; when the dystonia spreads to the lower face, tongue, and jaw, the condition is called Meige syndrome (G24.4) — a cranial dystonia. Per ICD-10-CM Guideline and the Excludes1 note at G24.5, drug-induced ** blepharospasm** must be coded to G24.01 and never to G24.5 — these two codes are mutually exclusive. First-line treatment is botulinum toxin injection (chemodenervation) into the orbicularis oculi; CPT 64612 is the primary procedure code.
The root blepharon derives from the Greek verb blephein — “to look” or “to glance” — making the eyelid literally “that which enables the look.” This root is productive across ophthalmology: blepharitis (eyelid inflammation), blepharoplasty (eyelid surgery), blepharoptosis (eyelid drooping), and blepharophimosis (narrowing of the palpebral fissure) all share it. The suffix -spasm traces to spasmos, from the verb spaein (“to draw” or “to pull”), and its Proto-Indo-European root speh- relates to stretching and pulling — giving English cognates spasm, span, and spastic. -spasm is a highly productive suffix in neurology: vasospasm, bronchospasm, hemifacial spasm, and laryngospasm all follow the same construction. The compound blepharospasm entered clinical English through 19th-century German and French neurology, parallel to its contemporaries in the dystonia literature, as systematic classification of involuntary movement disorders was formalized in European academic medicine.
🔀 ALIASES / ALTERNATE TERMS
Eyelid spasm(lay/clinical descriptor; direct translation of the compound)
Involuntary eyelid closure(clinical documentation language; reflects severe presentation)
Blepharospastic(adjective form — e.g., “blepharospastic episode,” “blepharospastic patient”)
Benign Essential Blepharospasm (BEB)(bilateral focal dystonia with no identifiable secondary cause — the most common clinical subtype)
Reflex blepharospasm(triggered by ocular surface irritation — blepharitis, dry eye, keratoconjunctivitis; resolves when the underlying condition is treated)
Secondary blepharospasm(blepharospasm attributable to an identifiable systemic or ocular condition)
Drug-induced blepharospasm(adverse effect of medications — neuroleptics, dopaminergic agents; codes to G24.01, NOT G24.5)
Functional blindness(extreme manifestation of sustained involuntary eyelid closure — documented to support medical necessity for chemodenervation)
Focal dystonia(category term; blepharospasm is a focal cranial dystonia affecting a single muscle group)
🔗 RELATED TERMS
Dystonia — the parent movement disorder category (G24); blepharospasm is a focal subtype of dystonia involving the eyelid musculature
Meige syndrome(G24.4) — cranial dystonia; BEB + oromandibular dystonia (involuntary tongue, jaw, facial spasms); the progressive extension of BEB
Hemifacial spasm — involuntary unilateral facial contractions; involves the same facial nerve anatomy but is typically vascular compression of CN VII, not dystonia; treated with same 64612CPT
Orbicularis oculi — the circular muscle surrounding the eye socket that executes the blink; the primary target muscle in blepharospasm and chemodenervation
Myokymia — benign, spontaneous, unilateral eyelid twitching (fasciculation); should be clinically distinguished from blepharospasm — far more common, far less severe, not a dystonia
Ptosis — drooping of the upper eyelid; may mimic or coexist with blepharospasm; H02.4xx — post-botox ptosis is a documented adverse effect of 64612
Blepharitis(H01.0x) — eyelid margin inflammation; can trigger reflex blepharospasm and is a known risk factor for developing BEB
Dry eye syndrome(H04.12x) — frequently co-presents with BEB; photophobia and ocular dryness often precede the development of blepharospasm by months to years
Photophobia — light sensitivity; a common sensory prodrome and co-symptom of BEB, documented to support medical necessity
Botulinum toxin — the primary therapeutic agent for blepharospasm; onabotulinumtoxinA (Botox), abobotulinumtoxinA (Dysport), incobotulinumtoxinA (Xeomin), rimabotulinumtoxinB (Myobloc)
chemodenervation — the procedure category; CPT 64612 — chemical destruction of nerve-muscle function by botulinum toxin injection into the orbicularis oculi
Spastic entropion(H02.04x) — inward rolling of the eyelid due to orbicularis spasm; may be directly caused by or co-occur with blepharospasm; sites and laterality required
Cervical dystonia(G24.3) — spasmodic torticollis; a related focal dystonia of the neck musculature; sometimes co-treated in the same encounter as ** blepharospasm**
CODING CORNER
🏥 ICD-10-CM CODES
Primary Code — Blepharospasm (No Laterality Required — G24.5 IS Billable)
Blepharospasm — billable; no laterality required; classified under G24 Dystonia → G20-G26 Extrapyramidal and movement disorders → Diseases of the nervous system
Excludes1 — Cannot Be Coded WITH G24.5 (Mutually Exclusive)
Drug-induced ** blepharospasm** — use when blepharospasm is caused by a medication (neuroleptics, dopaminergic agents); Excludes1 from G24.5 — these codes may NEVER be reported together
Chemodenervation of muscle(s); muscle(s) innervated by facial nerve, unilateral (e.g., for ** blepharospasm**, hemifacial spasm) — primary procedure code; add LT or RT for unilateral; report 64612-50 for bilateral
Chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (e.g., for chronic migraine) — NOT typically used for isolated BEB
J0585
Injection, onabotulinumtoxinA (Botox), 1 unit — most common agent for ** blepharospasm**; billed per unit; document dose injected per eye
Repair of brow ptosis (supraciliary, mid-forehead or coronal approach — surgical option for refractory BEB with brow involvement)
⚠️ Coding Note:G24.5 is a billable code with no laterality requirement — unlike most ophthalmic H-chapter codes, ** blepharospasm** is classified in the nervous system chapter and does not require right/left specification. The critical Excludes1 distinction: G24.01 (drug-induced blepharospasm) and G24.5 can NEVER be coded together — query the provider to confirm whether the blepharospasm is idiopathic/essential vs. medication-related before coding. For CPT 64612, Medicare reimburses per eye — bilateral ** blepharospasm** treatment requires 64612-50 (or 64612-LT and 64612-RT per payer preference); do not bill 64612 twice without a modifier. HCPCS J0585 (Botox) is billed per unit — since the early 2000s, Medicare has reimbursed J0585 per single unit, not per 100-unit vial; document the exact number of units injected per eye. Waste billing is permitted for botulinum toxin when the patient is the last of the day and unused portions of an opened vial must be discarded — document waste in the medical record. For Meige syndrome, code G24.4 (not G24.5) when the dystonia has spread beyond the eyelids to involve the lower face; G24.5 and G24.4 may be coded together if both focal regions are explicitly documented as distinct. For inpatient profee, G24.5 rarely drives a DRG independently but frequently appears as a secondary neurological diagnosis in admissions for falls, functional impairment, or medication adjustment. Aetna and most major payers (including Medicare) cover 64612 + J0585/J0586/J0587/J0588 for BEB when medical necessity is documented — functional impairment, prior conservative treatment failure, and provider specialty credentials (neurology or oculoplastic surgery) are typical payer requirements.
Crystal's MCW Coder Hub